Combining precision oncology and immunotherapy by targeting the MALT1 protease is a research paper published in Journal for ImmunoTherapy of Cancer (2022). On theSindex it has a DataRank of 0. It has been cited 30 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Deutsche Forschungsgemeinschaft
Grant: ID 210592381 – SFB 1054 A04
Deutsche Forschungsgemeinschaft
Grant: ID 360372040 – SFB 1335 P07
National Cancer Institute
Grant: P01 CA240239
National Institute of Allergy and Infectious Diseases
Grant: R01 AI123349
Melanoma Research Alliance
Grant: 827872
Melanoma Research Foundation
Grant: 718056
Deutsche Forschungsgemeinschaft
Grant: 210592381/SFB 1054
Control and Plasticity of Cell-Fate Decisions in the Immune System
Deutsche Forschungsgemeinschaft
Grant: unidentified
unidentified
Deutsche Forschungsgemeinschaft
Grant: 360372040/SFB 1335
Aberrant Immune Signals in Cancer
National Institutes of Health
Grant: 1P01CA240239-01
Strategies to Overcome Immune Resistance in Head and Neck Cancers
National Institutes of Health
Grant: 5R01AI123349-03
Cellular mechanisms by which exhausted T cell responses are restored
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals